Phathom Pharmaceuticals (NASDAQ:PHAT) Upgraded at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) to a strong-buy rating in a report published on Tuesday,Zacks.com reports. PHAT has been the subject of several other research reports. Needham & Company LLC restated a “buy” rating and issued a $28.00 price objective on shares of Phathom Pharmaceuticals in a report on […]
More Stories
Saudi Arabia Reports Aramco’s Administrative Building on Fire After Being Struck
By Aldgra Fredly A fire broke out at an administrative building owned by Saudi Arabia’s state-owned oil giant after it...
Who is Lisa Bonet? Recent News, Early Life, Marriage, and More
Readers often look for clear details about Lisa Bonet, the famous actress best known for playing Denise Huxtable on the...
US Hits Bank of America With $1.2 Billion in Penalties for Security Violations
By Jill McLaughlin The U.S. Treasury fined Bank of America $1.21 billion for violations of anti-money laundering and sanctions laws,...
Tens of Thousands of People Double-Enrolled, Removed From Obamacare: Officials
By Zachary Stieber Health officials poring over death records and other data have found that 189,000 people were improperly enrolled...
Consumer Prices Rise 0.6 Percent, Lifting Annual Inflation Above Expectations
By Andrew Moran Consumers faced higher monthly cost pressures in September as surging gasoline prices resulted in hotter annual inflation,...
Is Lanterns Season 2 Renewed? Plot, Release Date, and Episodes
Television series by Chris Mundy: Lanterns update! Fans are excited to know the renewal status of the famous superhero series...